Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM)

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 860-863

  Gibson, J Martin ^a   Westwood, Melissa ^a   Young, Robert J ^b   White, Anne ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 1; SULFONYLUREA;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETIC DIET; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT;

BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; RISK FACTORS;

EID: 0030059487     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.860     Document Type: Article

References (10)

1. Prewitt TE, Unterman TG, Glick R, Cole TG, Schmeisser D, Bowen PE, Langenberg P. 1992 Insulin-like growth factor I and low-density-lipoprotein cholesterol in women during high- and low-fat feeding. Am J Clin Nutr. 55:381-384.
2. Hoogerbrugge-v.d. Linden N, Jansen H, Hülsmann WC, Birkenhäger. 1989 Relationship between insulin-like growth factor-I and low-density lipoprotein cholestrol levels in primary hypothyroidism in women. Journal of Endocrinology. 123:341-345.
3. Ostlund Jr RE, Staten MA, Kohrt WM, Obert KA, Daughaday WH. 1991 Insulin-like growth factor and apolipoprotein B. JAMA. 266:1937-1938.
4. Oscarsson J, Lundstam U, Gustafsson B, Wilton P, Edén S, Wiklund O. 1995 Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clinical Endocrinology. 42:673-676.
5. Zenobi PD, Holzmann P, Glatz Y, Riesen WF, Froesch ER. 1993 Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor-I. Diabetologia. 36:465-469.
6. Schalch DS, Turman NJ, Marcsisin VS, Heffernan M, Guter HP. 1993 Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. J Clin Endocrinol Metab. 77:1563-1568.
7. Gibson JM, Westwood M, Crosby SR, Gordon C, Holly JMP, Fraser W, Anderson C, White A, Young RJ. 1995 Choice of treatment affects plasma levels of insulin-like growth factor binding protein-1 (IGFBP-1) in non insulin-dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab. 80:1369-1375.
8. Crosby SR, Tsigos C, Anderton CD, Gordon C, Young RJ, White A. 1991 Association of elevated insulin-like growth factor binding protein-1 (IGFBP-1) with peripheral neuropathy in type-1 diabetes. Diabetologia. 35:868-872.
9. Crosby SR, Anderton CD, Westwood M, Holly JMP, Cwyfan-Hughes SC, Gibson JM, Morrison CA, Young RJ, White A. 1993 Measurement of IGF-II in human plasma using a specific monoclonal antibody based two-site immunoradiometnc assay. J Endocrinol. 137:141-150.
10. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. 1994 The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab. 79:1735-1741.